Liuwei Dihuang Pills Enhance Osteogenic Differentiation in MC3T3-E1 Cells through the Activation of the Wnt/β-Catenin Signaling Pathway

Liuwei Dihuang Pills Enhance Osteogenic Differentiation in MC3T3-E1 Cells through the Activation of the Wnt/β-Catenin Signaling Pathway

Objective: The therapeutic efficacy and molecular mechanisms of traditional Chinese medicines (TCMs), such as Liuwei Dihuang pills (LWDH pills), in treating osteoporosis (OP) remain an area of active research and interest in modern medicine. This study investigated the mechanistic underpinnings of L...

Full description

Bibliographic Details
Main Authors:	Jinlong Zhao, Guihong Liang, Junzheng Yang, Hetao Huang, Yaoxing Dou, Zhuoxu Gu, Jun Liu, Lingfeng Zeng, Weiyi Yang
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Pharmaceuticals
Subjects:	Liuwei Dihuang pills osteogenic osteoporosis MC3T3-E1 cells Wnt/β-catenin signaling pathway
Online Access:	https://www.mdpi.com/1424-8247/17/1/99

Similar Items

Network pharmacology and molecular docking approach to elucidate the mechanisms of Liuwei Dihuang pill in diabetic osteoporosis
by: Zhaoqi Lu, et al.
Published: (2022-06-01)

Effect of Liuwei Dihuang Tang on ferroptosis pathway in retinal tissue of aging model rats
by: Zhang Qi, et al.
Published: (2024-03-01)

Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion
by: Xiaodong Zhu, et al.
Published: (2022-07-01)

DNA Extraction Protocol for Biological Ingredient Analysis of Liuwei Dihuang Wan
by: Xinwei Cheng, et al.
Published: (2014-06-01)

Comparison of Donepezil, Memantine, Melatonin, and Liuwei Dihuang Decoction on Behavioral and Immune Endocrine Responses of Aged Senescence-Accelerated Mouse Resistant 1 Mice
by: Ju Zeng, et al.
Published: (2020-04-01)

Efficacy of Co-administration of Liuwei Dihuang Pills and Ginkgo Biloba Tablets on Albuminuria in Type 2 Diabetes: A 24-Month, Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
by: Ruifeng Shi, et al.
Published: (2019-02-01)

Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Liuwei Dihuang Decoction Against Intervertebral Disc Degeneration
by: Zhang H, et al.
Published: (2021-12-01)

The neuroprotective effects of Liuwei Dihuang medicine in the APP/PS1 mouse model are dependent on the PI3K/Akt signaling pathway
by: Ye Yuan, et al.
Published: (2023-10-01)

The components transitive regularity of three dosage forms of Liuwei Dihuang Fufang
by: Zhu Junping, et al.
Published: (2022-03-01)

Liuwei Dihuang Decoction Alleviates Cognitive Dysfunction in Mice With D-Galactose-Induced Aging by Regulating Lipid Metabolism and Oxidative Stress via the Microbiota-Gut-Brain Axis
by: Baiyan Liu, et al.
Published: (2022-07-01)

Liuwei Dihuang formula ameliorates chronic stress-induced emotional and cognitive impairments in mice by elevating hippocampal O-GlcNAc modification
by: Yan Huang, et al.
Published: (2023-04-01)

LDP alleviates TKI-induced proteinuria through reversing the expression of RelA in renal tissues
by: Zhou Fu, et al.
Published: (2023-01-01)

Meta analysis of the efficacy and safety of Qiju Dihuang Pill in the treatment of dry eye
by: Xi-Li Xiao, et al.
Published: (2020-01-01)

Study on the treatment of postmenopausal osteoporosis with quercetin in Liuwei Dihuang Pill based on network pharmacology
by: Fuping Zhu, et al.
Published: (2023-01-01)

Liuwei Dihuang Pills in the Treatment of Senile Dementia: A Review
by: Jing GUO, et al.
Published: (2023-01-01)

A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus
by: He D, et al.
Published: (2019-11-01)

A Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of LiuWei DiHuang Pill in Treating Type 2 Diabetes Mellitus [Corrigendum]
by: He D, et al.
Published: (2020-03-01)

The Anti-diarrheal Activity of the Non-toxic Dihuang Powder in Mice
by: Xiaofei Shang, et al.
Published: (2018-09-01)

Deciphering the Mechanism of Xijiao Dihuang Decoction in Treating Psoriasis by Network Pharmacology and Experimental Validation
by: Guo Y, et al.
Published: (2023-09-01)

Multicomponent Analysis of Liuwei Dihuang Pills by a Single Marker Quantification Method and Chemometric Discrimination of Fingerprints
by: Lin Yang, et al.
Published: (2023-01-01)

iTRAQ-based proteomic analysis to identify the molecular mechanism of Zhibai Dihuang Granule in the Yin-deficiency-heat syndrome rats
by: Chang-Ming Liu, et al.
Published: (2018-01-01)

Exploring the Mechanism of Zhibai Dihuang Decoction in the Treatment of Ureaplasma Urealyticum-Induced Orchitis Based on Integrated Pharmacology
by: Dong-hua Bin, et al.
Published: (2021-05-01)

Dihuang-Yinzi Alleviates Cognition Deficits via Targeting Energy-Related Metabolism in an Alzheimer Mouse Model as Demonstrated by Integration of Metabolomics and Network Pharmacology
by: Guanghui Han, et al.
Published: (2022-04-01)

Analysis on therapy efficacy of different drugs for dry eyes after cataract surgery
by: Li-Ping Yang, et al.
Published: (2017-02-01)

Mechanisms of Dihuang (Rehmanniae Radix) in treating diabetic nephropathy complicated with depression based on network pharmacology
by: Lei Xing, et al.
Published: (2022-06-01)

Capsule endoscopy with PillCamSB2 versus PillCamSB3: has the improvement in technology resulted in a step forward?
by: Sofia Xavier, et al.

Integrated network pharmacology and brain metabolomics to analyze the mechanism of Dihuang Yinzi intervention in Alzheimer's disease
by: Jian Zhang, et al.
Published: (2024-03-01)

Compound Dihuang Granule Inhibits Nigrostriatal Pathway Apoptosis in Parkinson’s Disease by Suppressing the JNK/AP-1 Pathway
by: Li Wang, et al.
Published: (2021-04-01)

Corrigendum: Compound Dihuang Granule inhibits nigrostriatal pathway apoptosis in Parkinson’s disease by suppressing the JNK/AP-1 pathway
by: Li Wang, et al.
Published: (2023-12-01)

Bioinformatics-Based Approach for Exploring the Immune Cell Infiltration Patterns in Alzheimer’s Disease and Determining the Intervention Mechanism of Liuwei Dihuang Pill
by: Chenling Zhao, et al.
Published: (2022-07-01)

Uncovering the mechanism of Qidan Dihuang Granule in the treatment of diabetic kidney disease combined network pharmacology, UHPLC-MS/MS with experimental validation
by: Lei Xiang, et al.
Published: (2023-11-01)

Efficacy of Qiju Dihuang decoction combined with sodium hyaluronate eye drops in the treatment of xerophthalmia after cataract surgery
by: Min Zhao, et al.
Published: (2021-07-01)

PTX3 Effects on Osteogenic Differentiation in Osteoporosis: An In Vitro Study
by: Chiara Greggi, et al.
Published: (2021-05-01)

ANALYSIS OF AN ALTERNATIVE TECHNOLOGY FOR PREPARING AND APPLYING PILLS IN WELL DRILLING
by: Alexey S. Korolev, et al.
Published: (2023-01-01)

Fangji Dihuang formulation ameliorated DNCB-induced atopic dermatitis-like skin lesions by IL-17 signaling pathway: integrating network analysis and experimental validation
by: Wenting Zhao, et al.
Published: (2023-11-01)

Pills, Pills, and More Pills: A Pill Box Exercise to Teach Barriers to Medication Adherence and Solutions
by: Kathryn Denson, et al.
Published: (2015-11-01)

The mechanism by which Naru 3 pill protects against intervertebral disc cartilage endplate degeneration based on network pharmacology and experimental verification
by: Jialin Guo, et al.
Published: (2023-07-01)

The effects and mechanism of paeoniflorin in promoting osteogenic differentiation of MC3T3-E1
by: Wei Guo, et al.
Published: (2022-02-01)

Wnt/β-Catenin Signaling Inhibits Osteogenic Differentiation in Human Periodontal Ligament Fibroblasts
by: Ryoya Iizumi, et al.
Published: (2022-12-01)

The Effect of Selenium Nanoparticles on the Osteogenic Differentiation of MC3T3-E1 Cells
by: Sang-Cheol Lee, et al.
Published: (2021-02-01)